We have been collaborating for over a decade with leading educational and healthcare institutions.
To this day, our devices are featured in the most published research in the field of photobiomodulation.
We have been collaborating for over a decade with leading educational and healthcare institutions.
To this day, our devices are featured in the most published research in the field of photobiomodulation.
clinical research participants
clinical research participants
clinical research participants
PBM therapy led to improvements in gut microbiome composition in Parkinson’s disease patients. Most participants showed beneficial shifts in the Firmicutes-to-Bacteroidetes (F:B) ratio, a key indicator of gut health.
2021, School of Health Sciences, Australian Catholic University, North Sydney, NSW 2060, Australia
Patients undergoing PBM demonstrated greater improvements in executive function tests, including clock drawing, immediate recall, practical memory, visual attention, and task-switching.
2019, Quietmind Foundation, Elkins Park, Pennsylvania, USA
PBM enhances cerebrospinal fluid drainage, which could be crucial for treating conditions linked to impaired brain lymphatic function.
2022, School of Materials Science and Engineering, Hefei University of Technology, China
A meta-analysis found that combining cell therapy with PBM significantly improved Parkinson’s disease symptoms.
2022, Shahid Beheshti University of Medical Sciences, Laser Applications in Medical Sciences Research Center, Tehran, Iran
This study demonstrated that whole-body vibration exercise inhibits apoptotic neuronal death induced by intracerebral hemorrhage, thereby promoting the recovery of brain function after intracerebral hemorrhage.
Department of Exercise Physiology, Graduate School of Korea University, May 2012
These results suggest that hyperbaric oxygen therapy (HBOT) could be a useful medical treatment for cerebral infarction. Further studies involving more cases are needed to confirm the definitive effectiveness of HBOT in treating cerebral infarction.
Department of Internal Medicine, Dongseo Oriental Medicine Hospital, Republic of Korea, September 2008.
These results suggest that hyperbaric oxygen therapy (HBOT) could be a useful medical treatment for cerebral infarction. Further studies with more cases are necessary to confirm whether HBOT is definitively effective for treating cerebral infarction
Department of Hyperbaric Oxygen, Navy General Hospital, Beijing, China, August 2015
These parameters were significantly reversed by HBO, indicating that HBO can protect HT22 and PC12 cells from damage induced by oxygen-glucose deprivation/reperfusion. This protection is achieved through the suppression of ferroptosis mediated by the Nrf2/System Xc-/GPX4 axis
Department of Pharmacy, Guangxi Zhuang Autonomous Region and Guangxi People's Hospital, Nanning Medical Research Institute, Guangxi Province, China, September 2022
The current study provides preliminary evidence suggesting that HBOT treatment can reduce neuroinflammation through the inhibition of the NF-kB signaling pathway and promote neurogenesis via the activation of the CREB/BDNF pathway. Additionally, this therapy has the potential to improve mitochondrial biogenesis through the SIRT-1/PGC-1α-dependent signaling pathway and enhance dopamine function…
Department of Anesthesiology, Kaohsiung Medical University, Kaohsiung, Taiwan, April 2022
During visuospatial tasks, high-concentration oxygen administration sufficiently enhances oxygen supply, leading to greater activation of neural networks and improved performance in visuospatial tasks
Department of Biomedical Science and Engineering, Konkuk University, March 2005
HBOT induces significant improvements in all cognitive domains, even in the chronic phase following a stroke. When selecting stroke patients for HBOT, decisions should be based on functional assessment and baseline cognitive scores rather than the type, location, or side of the stroke lesion
Department of Neurosurgery, Galilee Medical Center, Nahariya, Israel, January 2020
Several randomized and randomized controlled trials have shown that HBOT at 1.5 ATA oxygen produces statistically significant results in symptomatic and cognitive improvements in patients with persistent post-concussion syndrome following mild traumatic brain injury
Department of Emergency Medicine, Division of Hyperbaric Medicine, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, Louisiana, USA, 2022
E-MAIL: info@huelight.kr I TEL : 02-898-2116 I HUE LIGHT CO., LTD SK Techno park E-1311. 60, Haan-ro, Gwangmyeong-si, Gyeonggi-do, Republic of Korea I Copyright 2024 © Hue Light Co., Ltd. All rights reserved
Disclaimer: The medical papers and academic information provided on this site are intended for educational purposes only and are not meant to diagnose, treat, prevent diseases, or substitute for a doctor’s advice.
Copyright 2024 © Hue Light Co., Ltd. All rights reserved
Disclaimer: The medical papers and academic information provided on this site are intended for educational purposes only and are not meant to diagnose, treat, prevent diseases, or substitute for a doctor’s advice.